Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine

Targeting the site of infection is a promising strategy for improving vaccine effectivity. To date, licensed COVID-19 vaccines have been administered intramuscularly despite the fact that SARS-CoV-2 is a respiratory virus. Here, we aim to induce local protective mucosal immune responses with an inha...

Descripción completa

Detalles Bibliográficos
Autores principales: Elder, Elizabeth, Bangalore Revanna, Chandrashekar, Johansson, Catharina, Wallin, Robert P.A., Sjödahl, Johan, Winqvist, Ola, Mirazimi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242152/
https://www.ncbi.nlm.nih.gov/pubmed/37353452
http://dx.doi.org/10.1016/j.vaccine.2023.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242152/
https://www.ncbi.nlm.nih.gov/pubmed/37353452
http://dx.doi.org/10.1016/j.vaccine.2023.06.015

Ejemplares similares